Jacob, G; Lieb, K; Berger, M
Schwierige Gesprächssituationen in Psychiatrie und Psychotherapie1. Aufl. München: Elsevier Urban & Fischer 2009 1 S.
Yakushev, I; Hammers, A; Fellgiebel, A et al.
SPM-based count normalization provides excellent discrimination of mild Alzheimer's disease and amnestic mild cognitive impairment from healthy aging.Neuroimage. Bd. 44. H. 1. 2009 S. 43-50
Wagner, S; Baskaya, Ö; Lieb, K et al.
The 5-HTTLPR Polymorphism modulates the association of Serious Life Events (SLE) and Impulsivity in Patients with Borderline Personality DisorderJ Psychiatr Res. Bd. 43. 2009 S. 1067-72
Freese, C; Garratt, AN; Fahrenholz, F et al.
The effects of alpha-secretase ADAM10 on the proteolysis of neuregulin-1FEBS J. Bd. 276. H. 6. 2009 S. 1568-80
Vogel, F; Gansmüller, R; Leiblein, T et al.
The use of ziprasidone in clinical practice: Analysis of pharmacokinetic and pharmacodynamic aspects from data of a drug monitoring surveyEur Psychiat. Bd. 24. H. 3. 2009 S. 143-148
Hiemke, C; Laux, G; Saria, A et al.
Therapeutisches Drug Monitoring in der forensischen PsychiatriePsychopharmakotherapie. Bd. 16. H. 2. 2009 S. 47
Hiemke, C
Therapeutisches Drug Monitoring in der Psychiatrie: Was besagen Plasmakkonzentrationen?F. Pragst, T. Arndt (Hrsg). GTFCh-Symposium 2009 Toxikologie psychisch aktiver Substanzen. Jena: Verlag Gesellschaft für Toxikologische und Forensische Chemie 2009
Hiemke, C
Therapeutisches Drug Monitoring und PolypharmazieMed Report. Bd. 33. H. 44. 2009 S. 8
Laux, G; Artmann, S; Gerl, S et al.
Therapeutisches Drug Monitoring von Psychopharmaka in der forensischen PsychiatriePsychopharmakotherapie. Bd. 16. H. 2. 2009 S. 48-51
van Calker, D; Zobel, I; Dykierek, P et al.
Time course of response to antidepressants: predictive value of early improvement and effect of additional psychotherapy.J Affect Disord. Bd. 114. H. 1-3. 2009 S. 243-53